CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
RAINBO MMRd-GREEN is an international, multicenter, phase III randomised trial wherein adjuvant pelvic external beam radiotherapy combined with and f...
Phase 3
Toronto, Canada and 59 other locations
This is a phase 2 study of investigational drug niraparib and TSR-042 in patients with advanced/recurrent endometrial cancer. The p ...
Phase 2
Toronto, Ontario, Canada and 6 other locations
This is a Phase III, 2-arm, randomized, open label, multicenter, global study assessing the efficacy and safety of puxitatug samrotecan compared to p...
Phase 3
Hamilton, Ontario, Canada and 318 other locations
Researchers are looking for new ways to treat people with endometrial cancer (EC) who have previously received treatment with plati...
Phase 3
Mississauga, Ontario, Canada and 243 other locations
DESTINY-Endometrial01 will investigate the efficacy of first-line T-DXd + rilvegostomig (Arm A) and/or T-DXd+ pembrolizumab (Arm B) when com...
Phase 3
Toronto, Ontario, Canada and 255 other locations
study to evaluate the efficacy and safety of dostarlimab versus carboplatin-paclitaxel in patients with MMR deficient relapse or advanced endometrial...
Phase 3
Toronto, Canada and 100 other locations
(paclitaxel + carboplatin) followed by maintenance durvalumab with or without olaparib for patients with newly diagnosed advanced or recurrent endometrial...
Phase 3
Toronto, Ontario, Canada and 201 other locations
as maintenance therapy in participants with advanced or recurrent endometrial cancer (EC) compared with the physician's choice of i...
Phase 3
Toronto, Ontario, Canada and 11 other locations
This study specifically aims to evaluate how well mocertatug rezetecan (Mo-Rez) works in treating Endometrial Cancer (EC) compared ...
Phase 3
Toronto, Ontario, Canada and 53 other locations
The study is divided into two cohorts (Cohort 1 and Cohort 2), to which participants will be enrolled based on the amount of human epidermal growth f...
Phase 3
Toronto, Canada and 205 other locations
Clinical trials
Research sites
Resources
Legal